Table 3 Clinical information of low-intermediate risk PC patients with low or high MAOA expression after RP-PLND. (L: low expression; H: high expression)
From: High monoamine oxidase a expression predicts poor prognosis for prostate cancer patients
MAOA-L | MAOA-H | P | MAOA-L | MAOA-H | P | |
|---|---|---|---|---|---|---|
cases (%) | cases (%) | cases (%) | cases (%) | |||
Age (years) | 50–71 | 53–71 | 0.13 | 50–71 | 53–71 | 0.98 |
(60.5 ± 10.5) | (62 ± 9) | (60.5 ± 10.5) | (62 ± 9) | |||
ECOG PS ≥ 1 | ||||||
No | 49(71.0%) | 25(54.3%) | 28(66.7%) | 25(59.5%) | ||
Yes | 20(29.0%) | 21(45.7%) | 0.077 | 14(33.3%) | 17(40.5%) | 0.65 |
Pathological stage | ||||||
< T2b | 26(37.7%) | 14(30.4%) | 14(33.3%) | 14(33.3%) | ||
T2b | 43(62.3%) | 32(69.6%) | 0.55 | 28(66.7%) | 28(66.7%) | 1 |
PSA (ng/mL) | ||||||
≤ 10 | 32(46.4%) | 12(26.1%) | 14(33.3%) | 12(28.6%) | ||
> 10 | 37(53.6%) | 34(73.9%) | 0.033 | 28(66.7%) | 30(71.4%) | 0.81 |
GS | ||||||
< 7 | 34(49.3%) | 13(28.3%) | 11( 26.2%) | 11(26.2%) | ||
7 | 35(50.7%) | 33(71.7%) | 0.033 | 31(73.8%) | 31(73.8%) | 1 |